title: [Topical gel formulation of ibuprofen in the treatment of acute and chronic joint and soft tissue pain. Results of a non-interventional observational trial].
abstract: BACKGROUND
  Pain, inflammation or swelling of soft tissues orjoints is often treated with oral or topical formulation of lbuprofen.
  
  
  METHODS
  Thetherapeutic effect of a topical gel formulation of Ibuprofen (doc Ibuprofen Schmerzgel) was investigated in an observational trial. A total of 170 patients suffering either from pain, inflammation or swelling of soft tissues or joints or having experienced a blunt trauma were enrolled into this study. Physicians and patients evaluated typical symptoms at study entry and after 1 week at the final visit. Further, the patients were asked and instructed to monitor their symptoms in a daily diary over this week.
  
  
  RESULTS
  Patientssufferingfromacute trauma (group A (symptoms existent up to 48 hours) as well as patients with chronic symptoms (group B) experienced a fast and prominent improvement of symptoms. In group A total reduction of all symptoms after one week was recorded to amount to considerably more than 80%, in group B a reduction of more than 50% compared to the initial scores could be seen. Evaluation done by physicians and patients were extremely concordant with regard to timecourse and final outcome of the treatment. After first use on day one group A noted a reduction of pain symptoms after approximately 25 minutes, while in group B a considerable relief of pain was reported after approximately 37 minutes. During this one-week treatment period no adverse-effects were reported.Tolerability and applicability were classified as good to excellent.
  
  
  CONCLUSIONS
  The results of this study confirm findings from existing clinical trials data. In acute traumata a faster symptom relief is found, in chronic conditions the product leads to symptom reduction in case seven where pretreatment has shown insufficient results. Thus this topical treatment provides a treatment option either alone or in combination with orally taken NSAIDS.
authors.affiliation: m.petersen_braun@me.com
authors.forename: M
authors.initials: M
authors.lastname: Petersen-Braun
authors.forename: T
authors.initials: T
authors.lastname: Wegener
mesh_terms: D059787:Acute Pain / Q000188:drug therapy*; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage*; D059350:Chronic Pain / Q000188:drug therapy*; D005260:Female; D005782:Gels; D058006:General Practice; D005858:Germany; D006801:Humans; D007052:Ibuprofen / Q000008:administration & dosage*; D008297:Male; D055118:Medication Adherence; D010147:Pain Measurement / Q000187:drug effects; D010489:Periarthritis / Q000188:drug therapy*; D014947:Wounds and Injuries / Q000188:drug therapy*; D055815:Young Adult
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D005782:Gels; D007052:Ibuprofen